Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.
about
Long-Term Toxicity of 213Bi-Labelled BSA in MiceTumor immunotargeting using innovative radionuclidesGold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapyRadioimmunotherapy with α-particle-emitting radionuclides.Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimatesTargeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.Folate receptor targeted alpha-therapy using terbium-149.Modelling and dosimetry for alpha-particle therapy.Microdosimetry for targeted alpha therapy of cancer.Matching chelators to radiometals for radiopharmaceuticals.Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry.Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutes.Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection.Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy.Structure and properties of DOTA-chelated radiopharmaceuticals within the Ac decay pathway
P2860
Q27317386-B88C0E77-65DF-42C0-A3E6-54887D2A4702Q28083230-C10F6D34-AA8D-49EE-ADBA-0F5881E9EDD3Q34324413-92AC0AB8-4CC2-4308-8038-908471B0D9C9Q34419562-5B6D16B3-C41E-4756-AC05-D514A4072550Q36928870-C9D1BE4E-EEDB-43B0-9471-F8B28151FF13Q37085052-F2600F57-5F19-4F0C-A005-1277B9477F4CQ37689807-B4F3FE17-B835-46A5-87DD-43A731C56A00Q37971507-F44972B1-8354-4EB2-BB51-D2F21F6CFF66Q38044389-2DDC4DFC-07A3-4801-8092-637D5B9FE373Q38156660-622577F3-5E2B-457F-A3FC-A224590973F4Q39413582-6CE7FC88-F7C5-4FB9-8EB7-5217C3461F0FQ40254341-FC41184B-62EF-4082-88C8-321ECE8B2DC5Q42174106-EDAF7351-7EBD-4A99-B650-9AEC58C17004Q48089417-AEE1DCAD-F5AD-498A-A343-69338C93FA54Q52632620-AB102DA6-6F2B-41FA-9256-7A213D9F6188Q57179186-1B517190-97CC-4B6D-B934-EAC167E14B7F
P2860
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@ast
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@en
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@nl
type
label
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@ast
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@en
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@nl
prefLabel
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@ast
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@en
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody.
@nl
P2093
P2860
P356
P1476
Renal uptake of bismuth-213 an ...... actinium-225-labeled antibody
@en
P2093
D A Scheinberg
J Schwartz
M McDevitt
S M Larson
P2860
P304
P356
10.1088/0031-9155/56/3/012
P577
2011-01-10T00:00:00Z